Prime Medicine (PRME) Change in Accured Expenses (2021 - 2026)

Prime Medicine has reported Change in Accured Expenses for 6 years, with the latest figure at -$4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 32.35% year-over-year to -$4.5 million; the trailing twelve-month figure through Mar 2026 stood at $993000.0 (up 394.66% YoY), and the FY2025 full-year result was -$1.2 million, down 162.94% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$4.5 million, down from $1.6 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $5.9 million in Q3 2024, with the low at -$33.3 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$1.6 million across 5 years, with a median of $608000.0 in 2023.
• The largest YoY upside for Change in Accured Expenses was 1211.11% in 2025 against a maximum downside of 118.06% in 2025.
• Prime Medicine's Change in Accured Expenses stood at $4.1 million in 2022, then tumbled by 38.53% to $2.5 million in 2023, then sank by 105.73% to -$144000.0 in 2024, then soared by 1211.11% to $1.6 million in 2025, then sank by 381.38% to -$4.5 million in 2026.
• The last three Change in Accured Expenses figures came in at -$4.5 million (Q1 2026), $1.6 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.